3,359
Views
9
CrossRef citations to date
0
Altmetric
Research Article

General practitioners’ and nurses’ views on medication reviews and potentially inappropriate medicines in elderly patients – a qualitative study of reports by educating pharmacists

, , , &
Pages 329-341 | Received 22 Mar 2018, Accepted 11 Apr 2018, Published online: 29 Jun 2018

References

  • Lavan AH, Gallagher P. Predicting risk of adverse drug reactions in older adults. Ther Adv Drug Saf. 2016;7:11–22.
  • Kongkaew C, Noyce PR, Ashcroft DM. Hospital Admissions Associated with Adverse Drug Reactions: A Systematic Review of Prospective Observational Studies. Ann Pharmacother. 2008;42:1017–1025.
  • Christensen M, Lundh A. Medication review in hospitalised patients to reduce morbidity and mortality. Cochrane Database Syst Rev 2016;2:CD008986.
  • O'Mahony D, O'Sullivan D, Byrne S, et al. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2014;44:213–218.
  • Rognstad S, Brekke M, Fetveit A, et al. The Norwegian General Practice (NORGEP) criteria for assessing potentially inappropriate prescriptions to elderly patients. A modified Delphi study. Scand J Prim Health Care. 2009;27:153–159.
  • O’Connor MN, Gallagher P, O'Mahony D. Inappropriate prescribing: criteria, detection and prevention. Drugs Aging. 2012;29:437–452.
  • Gillespie U, Alassaad A, Henrohn D, et al. A comprehensive pharmacist intervention to reduce morbidity in patients 80 years or older. Arch Intern Med. 2009;169:894–900.
  • Lenander C, Elfsson B, Danielsson B, et al. Effects of a pharmacist-led structured medication review in primary care on drug-related problems and hospital admission rates: a randomized controlled trial. Scand J Prim Health Care. 2014;32:180–186.
  • Odesjo H, Anell A, Boman A, et al. Pay for performance associated with increased volume of medication reviews but not with less inappropriate use of medications among the elderly - an observational study. Scand J Prim Health Care 2017;35:1–8.
  • Rahmner PB, Gustafsson LL, Holmstrom I, et al. Whose job is it anyway? Swedish general practitioners’ perception of their responsibility for the patient’s drug list. Ann Fam Med. 2010;8:40–46.
  • Cullinan S, Fleming A, O'Mahony D, et al. Doctors’ perspectives on the barriers to appropriate prescribing in older hospitalized patients: a qualitative study. Br J Clin Pharmacol. 2015;79:860–869.
  • Anderson K, Stowasser D, Freeman C, et al. Prescriber barriers and enablers to minimising potentially inappropriate medications in adults: a systematic review and thematic synthesis. BMJ Open. 2014;4:e006544.
  • Moen J, Norrgard S, Antonov K, et al. GPs’ perceptions of multiple-medicine use in older patients. J Eval Clin Pract. 2010;16:69–75.
  • Anthierens S, Tansens A, Petrovic M, et al. Qualitative insights into general practitioners views on polypharmacy. BMC Fam Pract. 2010;11:65
  • The National Board of Health and Welfare (Socialstyrelsen). SOSFS 2012:9 Ändring i föreskrifterna och allmänna råden (SOSFS 2000:1) om läkemedelshantering i hälso- och sjukvården [Changes in regulations and general advices regarding the handling of drugs in the health care system]. Västerås; 2012.
  • Murphy E, Dingwall R, Greatbatch D, et al. Qualitative research methods in health technology assessment: a review of the literature. Health Technol Assess 1998;2:1–274.
  • Schmidt-Mende K, Andersen M, Wettermark B, et al. Educational intervention on medication reviews aiming to reduce acute healthcare consumption in elderly patients with potentially inappropriate medicines-A pragmatic open-label cluster-randomized controlled trial in primary care. Pharmacoepidemiol Drug Saf 2017;26:1347–1356.
  • The National Board of Health and Welfare (Socialstyrelsen). National indicators for the quality of drug therapy in elderly persons. available at: http://www.socialstyrelsen.se/publikationer2010/2010-6-29. (accessed 16 September 2016).
  • Gustafsson LL, Wettermark B, Godman B, et al. The ‘wise list’- a comprehensive concept to select, communicate and achieve adherence to recommendations of essential drugs in ambulatory care in Stockholm. Basic Clin Pharmacol Toxicol. 2011;108:224–233.
  • Glenngård AH, Hjalte F, Svensson M, Anell A, et al. Health Systems in Transition: Sweden. available at: http://www.hpi.sk/cdata/Documents/HIT/Sweden_2005.pdf. (accessed 27 October 2017).
  • Forslund T, Wettermark B, Wandell P, et al. Risk scoring and thromboprophylactic treatment of patients with atrial fibrillation with and without access to primary healthcare data: experience from the Stockholm health care system. Int J Cardiol. 2013;170:208–214.
  • Braun V, Clarke V. Using thematic analysis in psychology. Qualitative Research in Psychology. 2006;3:77–101.
  • Mays N, Pope C. Qualitative research in health care: assessing quality in qualitative research. Br Med J. 2000;320:50.
  • Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19:349–357.
  • Szabo V, Strang VR. Secondary analysis of qualitative data. ANS Adv Nurs Sci. 1997;20:66–74.
  • Clyne B, Cooper JA, Hughes CM, et al. ‘Potentially inappropriate or specifically appropriate?’ Qualitative evaluation of general practitioners views on prescribing, polypharmacy and potentially inappropriate prescribing in older people. BMC Fam Pract. 2016;17:109.
  • Hedström M, Lidström B, Hulter Åsberg K. Phase-20: a new instrument for assessment of possible therapeutic drug-related symptoms among elderly in nursing homes. Vard Nord Utveckl Forsk 2009;29:9–14.
  • Sinnige J, Korevaar JC, van Lieshout J, et al. Medication management strategy for older people with polypharmacy in general practice: a qualitative study on prescribing behaviour in primary care. Br J Gen Pract. 2016;66:e540.
  • Barnett K, Mercer SW, Norbury M, et al. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet. 2012;380:37–43.
  • Kallio S, Kumpusalo-Vauhkonen A, Jarvensivu T, et al. Towards interprofessional networking in medication management of the aged: current challenges and potential solutions in Finland. Scand J Prim Health Care. 2016;34:368–376.
  • National Institute for Health and Care Excellence. Multimorbidity: clinical assessment and management. available at: https://www.nice.org.uk/guidance/ng56/evidence/full-guideline-pdf-2615543103. (accessed 5 may 2017).
  • Royal College of General practitioners. Responding to the needs of patients with multimorbidity. available at: http://www.rcgp.org.uk/policy/rcgp-policy-areas/integration-of-care.aspx. (accessed 27 October 2017).
  • van Summeren JJ, Schuling J, et al. Outcome prioritisation tool for medication review in older patients with multimorbidity: a pilot study in general practice. Br J Gen Pract 2017;67:e501–e506.
  • Bregnhøj L, Thirstrup S, Kristensen MB, et al. Prevalence of inappropriate prescribing in primary care. Pharm World Sci. 2007;29:109–115.
  • Rossi MI, Young A, Maher R, et al. Polypharmacy and health beliefs in older outpatients. Am J Geriatr Pharmacother. 2007;5:317–323.
  • Garfinkel D, Mangin D. Feasibility study of a systematic approach for discontinuation of multiple medications in older adults: addressing polypharmacy. Arch Intern Med. 2010;170:1648–1654.
  • Johnell K, Klarin I. The relationship between number of drugs and potential drug-drug interactions in the elderly: a study of over 600,000 elderly patients from the Swedish Prescribed Drug Register. Drug. Saf 2007;30:911–918.
  • Salvi F, Marchetti A, D’Angelo F, et al. Adverse drug events as a cause of hospitalization in older adults. Drug Saf. 2012;35 Suppl 1: 29–45.
  • Dreischulte T, Donnan P, Grant A, et al. Safer Prescribing–A Trial of Education, Informatics, and Financial Incentives. N Engl J Med. 2016;374:1053–1064.
  • Dumbreck S, Flynn A, Nairn M, et al. Drug-disease and drug-drug interactions: systematic examination of recommendations in 12 UK national clinical guidelines. BMJ 2015;350:h949.
  • Center for Family and Community Medicine. Safe Medication Assessment. available at: http://www.viss.nu/Global/Blanketter/SMA_verktyg_for_saker_lakemedelsanvandning_maj_2012.pdf. (accessed 20 October 2017).